Concepedia

Fangjun Chen

FC

Statistics

Publications

20

Citations

1.4K

H-Index

15

Active since

2013

Affiliations

Nanjing Drum Tower Hospital(Current)

Nanjing Medical University

Jiangsu Cancer Hospital

Nanjing University

Changzhou No.2 People's Hospital

Fangjun Chen is an author at Nanjing Drum Tower Hospital specializing in oncology, immunotherapy, and immunology.

ORCID

Publications per year

2013–2022

20

Publications

20

CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients

Shu Su, Bian Hu, Jie Shao et al. · Scientific Reports · 2016 · 303 citations · Full text

, , +17

Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors

Fangjun Chen, Zhengyun Zou, Juan Du et al. · Journal of Clinical Investigation · 2019 · 228 citations · Full text

, , +17

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer

Naiqing Ding, Zhengyun Zou, Huizi Sha et al. · Nature Communications · 2019 · 127 citations · Full text

, , +17

Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis

Hai‐Wei Xie, Qingquan Wu, Bin Zhu et al. · Tumor Biology · 2014 · 109 citations

, , +17

CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer

Shu Su, Zhengyun Zou, Fangjun Chen et al. · OncoImmunology · 2016 · 99 citations · Full text

, , +17

1–5 of 20